Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDO1 Antikörper

Der Kaninchen Polyklonal Anti-IDO1-Antikörper wurde für WB, ELISA, IHC und ICC validiert. Er ist geeignet, IDO1 in Proben von Maus zu detektieren. Es sind 4+ Publikationen verfügbar.
Produktnummer ABIN1169195

Kurzübersicht für IDO1 Antikörper (ABIN1169195)

Target

Alle IDO1 Antikörper anzeigen
IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reaktivität

  • 84
  • 31
  • 16
  • 9
  • 1
  • 1
  • 1
Maus

Wirt

  • 77
  • 16
  • 1
  • 1
Kaninchen

Klonalität

  • 68
  • 27
  • 1
Polyklonal

Konjugat

  • 67
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IDO1 Antikörper ist unkonjugiert

Applikation

  • 74
  • 36
  • 36
  • 23
  • 16
  • 16
  • 15
  • 14
  • 12
  • 12
  • 6
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC)
  • Spezifität

    Recognizes mouse IDO. Detects a band of ~45 kDa by Western blot.

    Kreuzreaktivität

    Maus

    Sterilität

    0.2 μm filtered

    Immunogen

    Recombinant mouse IDO.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    Lot specific

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.

    Konservierungsmittel

    Without preservative

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 6 months after receipt when stored at -20°C.

    Haltbarkeit

    6 months
  • Jung, Lee, Chang, Lee, Jeong, Lee, Park, Han, Seo, Lee, Park: "Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 5, pp. 3146-54, (2009) (PubMed).

    Yen, Lin, Chen, Huang, Yang, Chang, Lei, Lai: "A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, Issue 2, pp. 641-9, (2009) (PubMed).

    Cook, Bickerstaff, Wang, Nadasdy, Della Pelle, Colvin, Orosz: "Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 180, Issue 5, pp. 3103-12, (2008) (PubMed).

    Yadav, Burudi, Alirezaei, Flynn, Watry, Lanigan, Fox: "IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4." in: Glia, Vol. 55, Issue 13, pp. 1385-96, (2007) (PubMed).

  • Target

    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

    Andere Bezeichnung

    IDO

    Hintergrund

    IDO catalyzes the first and rate-limiting step in the main pathway of human tryptophan catabolism, the kynurenine pathway. Proinflammatory mediators, such as endotoxin and IFN-gamma induce the expression of IDO in several tissues. IDO-dependent suppression of T-cell responses might function as natural immunoregulatory mechanism. Physiological IDO activity has been implicated in T-cell tolerance to tumors, dysfunctional selftolerance in non-obese diabetic (NOD) mice, and as a protective negative regulator in autoimmune disorders.

    UniProt

    P28776

    Pathways

    Activated T Cell Proliferation
Sie sind hier:
Chat with us!